Equifax
EFX · NYSE
About EFX
- Employees
- 15,000
- Headquarters
- Atlanta, Georgia
- Listed
- May 11, 1971
- Sector
- Industrials
- Industry
- Professional Services
- Website
- equifax.com
EFX key statistics
- Market cap
- 18.63B
- Price-earnings ratio
- 27.92
- Dividend yield
- 1.37%
- Average volume
- 1.99M
- Volume
- 2.82M
- Open price
- $166.11
- High today
- $177.80
- Low today
- $166.11
- 52 Week high
- $238.94
- 52 Week low
- $137.01
Equifax (EFX) at a glance
Equifax (EFX) last traded at $176.54, with a market cap of 18.63B, a price-to-earnings ratio of 27.92 and a dividend yield of 1.37%.
Today the stock has traded between $166.11 and $177.80. The current price is 6.3% above the day's low and 0.7% below its high.
Volume so far is 2.82M shares, above the average of 1.99M shares a day.
Over the past year Equifax has ranged from $137.01 to $238.94, and now sits 39% of the way up that range.
Equifax met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q3 FY26 it reported $2.26 per share against an estimate of $2.22.
The average analyst price target is $215.54, 22.1% above the current price, from 16 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy68.8%
- Hold31.3%
- Sell0.0%
- Low
- $161.60
- Now
- $176.54
- High
- $257.25
EFX earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 8 of the last 8 quarters, by 3.5% on average.
- Q4 FY24: reported $2.12 per share against an estimate of $2.12
- Q1 FY25: reported $1.53 per share against an estimate of $1.42
- Q2 FY25: reported $2.00 per share against an estimate of $1.94
- Q3 FY25: reported $2.04 per share against an estimate of $1.95
- Q4 FY25: reported $2.09 per share against an estimate of $2.07
- Q1 FY26: reported $1.86 per share against an estimate of $1.72
- Q2 FY26: reported $2.25 per share against an estimate of $2.22
- Q3 FY26: reported $2.26 per share against an estimate of $2.22
EFX news
- Lekha Gupta
- Piero Cingari
Health Care Stocks Hit Record Highs, GM Drops Nearly 8%: Stock Market Today
Equifax Q3 2026 Earnings Call Transcript
- Press releasePRNewswire
Equifax Delivers Strong 10% Revenue Growth in Third Quarter 2026 Driven by 8% Diversified Markets Revenue Growth Despite Challenging U.S. Mortgage Market; Returns $158 Million Cash to Shareholders
- Piero Cingari
Earnings Volatility Watch: Bloom Energy and Other 11 Stocks Are Priced For Double-Digit Swings
- Press releasePRNewswire
Equifax expands access to cash flow data solutions for confident decisioning
- Press releasePRNewswire
Equifax announces Mortgage Ultimate™ with adaptive automation for seamless, expansive verification coverage
- Press releasePRNewswire
Equifax Mortgage Score Select™ Supports Dual Score Approach
Similar companies
Companies in the same industry as Equifax
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.